Taysha Gene Therapies Inc. (TSHA)
NASDAQ · Healthcare
Taysha Gene Therapies Inc. EPS 2022–2025
Taysha Gene Therapies Inc. annual/quarterly eps history and growth rate from 2022 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Taysha Gene Therapies Inc. eps for the quarter ending March 31, 2026 was $0.12, a 50.00% increase year-over-year.
- Taysha Gene Therapies Inc. annual eps for 2025 was $0.34, a 5.56% decrease from 2024.
- Taysha Gene Therapies Inc. annual eps for 2024 was $0.36, a 62.50% decrease from 2023.
- Taysha Gene Therapies Inc. annual eps for 2023 was $0.96, a 74.60% decrease from 2022.
- Taysha Gene Therapies Inc. annual eps for 2022 was $3.78.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Taysha Gene Therapies Inc. EPS — FAQ
Taysha Gene Therapies Inc. (TSHA) eps over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Taysha Gene Therapies Inc.'s eps?
Taysha Gene Therapies Inc. (TSHA) reported eps of $-0.34 for fiscal 2025.
Where can I see TSHA's eps history?
The chart and table above show Taysha Gene Therapies Inc.'s eps by year and by quarter, including the growth rate.